Akums Drugs, a company that makes medicines, is now offering its shares to the public through an Initial Public Offering (IPO). This means you have the chance to buy a part of the company and potentially profit from its future success. Here’s everything you need to know about the Akums Drugs IPO.
Important Dates and Details
- IPO GMP: The shares are currently available at a premium of ₹181 in the grey market.
- IPO Price: The price band is set at ₹646 to ₹679 per share.
- IPO Dates: The offer is open from July 30 to August 1, 2024.
- IPO Size: The company plans to raise ₹1,856.74 crore, with ₹1,176.74 crore coming from an Offer for Sale (OFS).
- Lot Size: Investors can apply in lots, with one lot comprising 22 shares.
- Allotment Date: Share allocation is expected on August 2, 2024.
- Registrar: Link Intime India Private Ltd is the official registrar for the IPO.
- Listing: The shares will be listed on both the BSE and NSE.
- Listing Date: The shares are expected to start trading on August 6, 2024, under the ‘T+3’ listing rule.
Should You Invest?
Deciding to invest in an IPO is not easy. Here are some things to consider:
- Company Performance: Look at how the company has done in the past. Check its profits, sales, and debts.
- IPO Price: Compare the IPO price to the company’s value. Is it overpriced or underpriced?
- Market Conditions: The overall stock market can affect the IPO’s performance.
- Risk Tolerance: Are you comfortable with losing money? Investing in stocks involves risk.
It’s important to do your own research or talk to a financial advisor before investing.
Investing in the Akums Drugs IPO could be an exciting opportunity, but it also comes with risks. Make sure to review all the relevant information and consider your financial situation before making a decision. Remember, investing in the stock market should be done with caution and an understanding of the potential risks involved.
